Items tagged with Access
Over the last couple of years, news of pharmaceutical patents and India’s attempts to protect and manage its market has caught the attention of intellectual property observers everywhere and the pharmaceutical industry in particular.
Despite minimal concessions, US demands remain extremely dangerous to all patients’ health across the Asia-Pacific region
This industry needs to forget about intellectual property and pool resources if it is to have any real hope of discovering innovative new medicines, a leading scientist claims.
Phakama Clinic is one of the 23 urban clinics supported since 2012 through The Union’s TB CARE project in 17 urban areas of Zimbabwe. Located in a high-density suburb of the City of Gwanda, provincial capital of Matabeleland South Province, Phakama Clinic is the only one participating in the project that is run by the local authority.
UNITAID is expected to soon publish a report on the implications of the leaked provisions of the Trans-Pacific Partnership agreement (TPP) on public health and access to medicines.
An article published in the March 2014 issue of the World Health Organization Bulletin discusses the evolving issue of access to medicines in Africa.
Myanmar: MSF to resume HIV/AIDS and other activities in Kachin, Shan and Yangon, but concerns remain (post)
Yangon/New York, March 1, 2014 -- On February 27, Médecins Sans Frontières Holland (MSF) received a written order from the Union Government of Myanmar to cease all operations in the country, which led to a full closure of all MSF Holland clinics on February 28. This act left patients confused and desperately concerned across the whole country.
MSF: Two new studies point to impact of HIV treatment on transmission in high-HIV-burden African contexts (post)
Results also show viral suppression in one Malawian district twice as high as in the US
A matter of life and death (post)
Martin Khor, executive director of the South Centre, warns that negotiations on the Trans Pacific Partnership Agreement are a matter of life and death.
A leading UK university has reacted with bemusement to criticism from Medecins Sans Frontieres about a report it has published regarding the financing of future research at a time when innovative drugmakers are struggling to get what they perceive are fair prices for their therapies.
Page 2 of 49 · Total posts: 0←First 1 2 3 Last→